Targeting EZH2 functions

被引：0
|
作者：
Kleer, C. G.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-ES13-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES13-1
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
    Bohan Wang
    Yachong Liu
    Zhibin Liao
    Haofeng Wu
    Bixiang Zhang
    Lei Zhang
    Experimental Hematology & Oncology, 12
  • [42] Inhibition of pancreatic cancer by targeting the epigenetic EZH2 complex.
    Lomberk, Gwen Alyce
    Mathison, Angela
    Missfeldt, Mckenna
    Salmonson, Ann
    Kossak, Sarah
    Buttar, Navtej
    Urrutia, Raul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
    Wang, Bohan
    Liu, Yachong
    Liao, Zhibin
    Wu, Haofeng
    Zhang, Bixiang
    Zhang, Lei
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
  • [44] Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma
    Pikman, Yana
    Conway, Amy Saur
    Robichaud, Amanda L.
    Kitara, Samuel
    Church, Alanna J.
    Kennedy, Alyssa L.
    Silverman, Lewis B.
    Billett, Amy L.
    Weinstock, David M.
    Harris, Marian H.
    Stegmaier, Kimberly
    BLOOD ADVANCES, 2020, 4 (07) : 1265 - 1269
  • [45] Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma
    Al Emran, Abdullah
    Fisher, David E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (04) : 1004 - 1006
  • [46] Naturally occurring anti-cancer agents targeting EZH2
    Shahabipour, Fahimeh
    Caraglia, Michele
    Majeed, Muhammed
    Derosa, Giuseppe
    Maffioli, Pamela
    Sahebkar, Amirhossein
    CANCER LETTERS, 2017, 400 : 325 - 335
  • [47] THERAPEUTIC TARGETING OF EZH2 AND BET BRD4 IN AT/RT
    Zhang, Ali
    Piunti, Andrea
    Ozark, Patrick
    He, Xingyao
    Katagi, Hiroaki
    Sasaki, Takahiro
    Laurie, Kathryn
    Goldman, Stewart
    Zou, Lihua
    Shilatifard, Ali
    Hashizume, Rintaro
    NEURO-ONCOLOGY, 2019, 21 : 63 - 63
  • [48] Novel PROTAC-based EZH2 Degraders Effectively Target Lymphoid Malignancies by Depleting Enzyme-Independent Functions of EZH2
    Mustafa, Nurulhuda
    Alnaseri, Zubaida Talal
    Jian, Darrel Tan Egk
    Truong, David Quach Thanh
    Lim, Wan Hsin
    Chng, Wee Joo
    CANCER RESEARCH, 2024, 84 (08)
  • [49] Noncanonical functions of EZH2 in triple-negative breast cancers
    Anwar, Talha
    Moore, Heather
    Bergholtz, Sarah
    Kleer, Celina
    CANCER RESEARCH, 2015, 75
  • [50] Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer
    Anwar, Talha
    Gonzalez, Maria E.
    Kleer, Celina G.
    AMERICAN JOURNAL OF PATHOLOGY, 2021, 191 (05): : 774 - 783
12345